Truist lowered the firm’s price target on HCA Healthcare (HCA) to $495 from $520 and keeps a Buy rating on the shares. Truist remains upbeat on the core fundamentals in the Hospital sector, expects a solid operating backdrop driven by continued strong demand trends, solid utilization and look for ongoing capital deployment aimed at investment in core growth and shareholder value creation, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA: